Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Björkqvist, Maria ^a   Ohlsson, Mattias ^b   Minthon, Lennart ^c,d   Hansson, Oskar ^c,d  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; DEATH RECEPTOR 4; EPIDERMAL GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 11; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1DELTA; MONOCYTE CHEMOTACTIC PROTEIN 7; PLASMA PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN ANG 21; PROTEIN MMSE; PROTEIN PARC; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL15 PROTEIN, HUMAN; MACROPHAGE INFLAMMATORY PROTEIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE MARKER; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; BLOOD; DEMENTIA; MIDDLE AGED; PREDICTIVE VALUE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CHEMOKINES, CC; DEMENTIA; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-SIS; ROC CURVE;

EID: 84855975889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029868     Document Type: Article

References (26)

1. Blennow K, de Leon MJ, Zetterberg H, (2006) Alzheimer's disease. Lancet 368: 387-403.
2. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
3. Jack CRJ, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology 9: 119-128.
4. Perrin RJ, Fagan AM, Holtzman DM, (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461: 916-922.
5. Blennow K, Hampel H, Weiner M, Zetterberg H, (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131-144.
6. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, et al. (2010) Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9: 560-574.
7. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, et al. (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302: 385-393.
8. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, et al. (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5: 228-234.
9. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, et al. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65: 403-413.
10. Ray S, Britschgi M, Herbert C, Takeda-Ushimara, Boxer A, et al. (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13: 1359-1362.
11. Association AP, (1987) Diagnostic and Statistical Manual of Mental Disorders. third, revised ed Washington DC American Psychiatric Association.
12. McKhann G, Drachman D, Folstein M, Folstein M, Katzman R, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
13. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masde JC, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
14. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, et al. (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59 pp. 23-30.
15. McKeith IG, Perry EK, Perry RH, (1999) Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 53: 902-905.
16. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, et al. (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58: 1803-1809.
17. Hosmer D, Lemeshow S, (1989) Applied logistic regression New York Wiley.
18. Bishop CM, (1995) Neural Networks for Pattern Recognition Oxford Oxford University Press.
19. Tibshirani R, Hastie T, Narasimhan B, Chu G, (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proceedings of the National Academy of Sciences of the United States of America 99: 6567-72.
20. Breiman L, (1996) Bagging predictors, Machine Learning 24: 123-140.
21. Gòmez Ravetti M, Moscato P, (2008) Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease. PLoS ONE 3: e3111.
22. Soares HD, Chen Y, Sabbagh M, Rohrer A, Schrijvers E, et al. (2009) Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels. Annals of the New York Academy of Sciences 1180: 56-67.
23. Rocha de Paula M, Gòmez Ravetti M, Berretta R, Moscato P, (2011) Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical alzheimer's disease. PLoS ONE 6 (3): e17481 doi:10.1371/journal.pone.0017481.
24. Marksteiner J, Kemmler G, Weiss EM, Knaus G, Ullrich C, et al. (2011) Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiology of aging 3: 539-40.
25. Knudsen LS, Christensen IJ, Lottenburger T, Svendsen MN, Nielsen L, et al. (2008) Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis. Biomarkers 13: 59-78.
26. Ioannidis JP, Panagiotou OA, (2011) Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subseuquent meta-analyses. JAMA 21: 2200-10.